|
GB8906795D0
(en)
|
1989-03-23 |
1989-05-10 |
Carroll Noel |
Method of preparing vaccines
|
|
SE466259B
(sv)
|
1990-05-31 |
1992-01-20 |
Arne Forsgren |
Protein d - ett igd-bindande protein fraan haemophilus influenzae, samt anvaendning av detta foer analys, vacciner och uppreningsaendamaal
|
|
CA2059693C
(en)
|
1991-01-28 |
2003-08-19 |
Peter J. Kniskern |
Polysaccharide antigens from streptococcus pneumoniae
|
|
IL112372A
(en)
|
1994-02-07 |
2001-08-26 |
Res Dev Foundation |
Non-viral vector for the delivery of genetic information to cells
|
|
NZ304715A
(en)
|
1995-03-22 |
1999-07-29 |
Jackson H M Found Military Med |
Production of immunogenic constructs using organic cyanylating reagents to activate carbohydrates and then coupling the carbohydrate to a protein, peptide or hapten
|
|
DE69738597T2
(de)
|
1996-02-09 |
2008-07-24 |
Glaxosmithkline Biologicals S.A. |
Vakzine gegen das varicella zostervirus produkt von gen 63
|
|
JP4469026B2
(ja)
|
1996-10-31 |
2010-05-26 |
ヒューマン ジノーム サイエンシーズ，インコーポレイテッド |
Ｓｔｒｅｐｔｏｃｏｃｃｕｓ ｐｎｅｕｍｏｎｉａｅの抗原およびワクチン
|
|
DE69826851T2
(de)
|
1997-04-24 |
2005-02-10 |
Henry M. Jackson Foundation For The Advancement Of Military Medicine |
Kopplung unmodifizierter proteinen an haloacyl- oder dihaloacyl-derivatisierten polysacchariden zur herstellung von protein-polysaccharide impfstoffen
|
|
US6800744B1
(en)
|
1997-07-02 |
2004-10-05 |
Genome Therapeutics Corporation |
Nucleic acid and amino acid sequences relating to Streptococcus pneumoniae for diagnostics and therapeutics
|
|
JP2001510031A
(ja)
|
1997-07-21 |
2001-07-31 |
ノース・アメリカン・ヴァクシン・インコーポレーテッド |
ワクチンとしての修飾された免疫原ニューモリシン組成物
|
|
US7060458B1
(en)
|
1997-08-14 |
2006-06-13 |
Wyeth |
Nucleic acid and amino acid sequences relating to Staphylococcus epidermidis for diagnostics and therapeutics
|
|
US6287568B1
(en)
|
1997-09-09 |
2001-09-11 |
The Trustees Of Columbia University In The City Of New York |
Methods relating to immunogenic dextran-protein conjugates
|
|
US6248558B1
(en)
|
1998-03-31 |
2001-06-19 |
Vanderbilt University |
Sequence and method for genetic engineering of proteins with cell membrane translocating activity
|
|
CN1318103A
(zh)
|
1998-07-27 |
2001-10-17 |
微生物技术有限公司 |
肺炎链球菌的核酸和蛋白质
|
|
DE69935986D1
(de)
|
1998-07-27 |
2007-06-14 |
Sanofi Pasteur Ltd |
Streptococcus pneumoniae proteine und nukleinsäuren
|
|
GB9928678D0
(en)
|
1999-12-03 |
2000-02-02 |
Provalis Uk Ltd |
Streptococcus pneumoniae antigens
|
|
US8246945B2
(en)
|
2000-04-06 |
2012-08-21 |
University Of Arkansas |
Methods and reagents for decreasing clinical reaction to allergy
|
|
GB0107658D0
(en)
|
2001-03-27 |
2001-05-16 |
Chiron Spa |
Streptococcus pneumoniae
|
|
GB0118249D0
(en)
|
2001-07-26 |
2001-09-19 |
Chiron Spa |
Histidine vaccines
|
|
WO2003044185A2
(en)
|
2001-11-21 |
2003-05-30 |
Affinium Pharmaceuticals, Inc. |
Purified polypeptides involved in general metabolism
|
|
NZ536859A
(en)
|
2002-05-14 |
2007-11-30 |
Chiron Srl |
Mucosal combination vaccines for bacterial meningitis
|
|
ES2451620T3
(es)
|
2002-11-07 |
2014-03-28 |
Synergy America, Inc. |
Composiciones y métodos destinados a tratar o prevenir la infección neumocócica
|
|
US20060251675A1
(en)
|
2003-03-17 |
2006-11-09 |
Michael Hagen |
Mutant cholera holotoxin as an adjuvant and an antigen carrier protein
|
|
EP2333114A1
(en)
|
2003-04-15 |
2011-06-15 |
Intercell AG |
S. pneumoniae antigens
|
|
CA2524853A1
(en)
|
2003-05-07 |
2005-01-20 |
Aventis Pasteur, Inc. |
Method of enhanced immunogenicity to meningococcal vaccination
|
|
GB0318688D0
(en)
|
2003-08-08 |
2003-09-10 |
Chiron Srl |
Streptococcus pneumoniae knockout mutants
|
|
AU2004281634B2
(en)
|
2003-09-03 |
2011-01-27 |
Dendritherapeutics, Inc. |
Multiplex vaccines
|
|
US20050112139A1
(en)
|
2003-10-23 |
2005-05-26 |
Nmk Research, Llc |
Immunogenic composition and method of developing a vaccine based on factor H binding sites
|
|
WO2005076696A2
(en)
|
2004-02-13 |
2005-08-25 |
Sanofi Pasteur Limited |
Pneumolysin derivatives
|
|
US20050226899A1
(en)
|
2004-04-08 |
2005-10-13 |
Mauro Castiglioni |
Cosmetic mask composition
|
|
EP1740604A2
(en)
|
2004-04-27 |
2007-01-10 |
Intercell AG |
Td antigens
|
|
GB0410220D0
(en)
|
2004-05-07 |
2004-06-09 |
Kirkham Lea Ann |
Mutant pneumolysin proteins
|
|
JP2008509682A
(ja)
|
2004-08-18 |
2008-04-03 |
ガヴァナーズ オブ ザ ユニヴァーシティー オブ アルバータ |
Ｙｅｂｆを利用するタンパク質の製造方法
|
|
FI20041396A0
(fi)
|
2004-10-29 |
2004-10-29 |
Vesa Pekka Hytoenen |
Uudet mikrobiavidiinit
|
|
GB0428394D0
(en)
|
2004-12-24 |
2005-02-02 |
Chiron Srl |
Saccharide conjugate vaccines
|
|
WO2006084466A2
(en)
|
2005-02-11 |
2006-08-17 |
Ace Biosciences A/S |
Surface-located streptococcus pneumoniae polypeptides
|
|
CA2604363C
(en)
|
2005-04-08 |
2015-06-16 |
Wyeth |
Multivalent pneumococcal polysaccharide-protein conjugate composition
|
|
US20090148894A1
(en)
|
2005-08-15 |
2009-06-11 |
Broedel Sheldon E |
Methods for optimizing the secretion of protein in prokaryotes
|
|
NZ598367A
(en)
|
2005-09-01 |
2013-10-25 |
Novartis Vaccines & Diagnostic |
Multiple vaccination including serogroup C meningococcus
|
|
JP5564181B2
(ja)
|
2005-12-08 |
2014-07-30 |
シルワン，ハヴァル |
免疫刺激組成物および方法
|
|
WO2007081583A2
(en)
|
2006-01-04 |
2007-07-19 |
Children's Medical Center Corporation |
Anti-pneumococcal preparations and methods of use
|
|
US7943133B2
(en)
|
2006-02-02 |
2011-05-17 |
Boston Biocom Llc |
Mesothelin antibody protein fusions and methods of use
|
|
US20080032340A1
(en)
|
2006-06-09 |
2008-02-07 |
University Of Arizona |
Peptide motifs for binding avidin or neutravidin
|
|
US8148084B2
(en)
|
2006-06-22 |
2012-04-03 |
Dana-Farber Cancer Institute, Inc. |
Diagnosis of autoimmune disease
|
|
WO2007150020A1
(en)
|
2006-06-23 |
2007-12-27 |
Simon Paul M |
Targeted immune conjugates
|
|
US7452985B2
(en)
|
2006-08-17 |
2008-11-18 |
Visgeneer, Inc. |
Human Ron-related gene variant associated with cancers
|
|
WO2008152448A2
(en)
|
2006-12-21 |
2008-12-18 |
Emergent Product Development Uk Limited |
Streptococcus proteins, and their use in vaccination
|
|
CN100579152C
(zh)
|
2007-01-29 |
2010-01-06 |
华为技术有限公司 |
一种播放集团彩铃的方法、系统及装置
|
|
JP5714230B2
(ja)
|
2007-01-31 |
2015-05-07 |
フェネックス インコーポレイテッド |
発現上昇のための細菌リーダー配列
|
|
WO2008119358A2
(en)
|
2007-03-30 |
2008-10-09 |
Ace Biosciences A/S |
Surface-located streptococcus pneumoniae polypeptides for use in vaccine compositions
|
|
CA2683748C
(en)
|
2007-04-13 |
2016-02-16 |
The Board Of Regents Of The University Of Oklahoma |
Mutants of cholesterol-dependent cytolysins and uses thereof
|
|
SI2167121T1
(sl)
|
2007-06-26 |
2015-12-31 |
Glaxosmithkline Biologicals S.A. |
Cepivo, ki obsega kapsularne polisaharidne konjugate Streptococcusa pneumoniae
|
|
GB0714963D0
(en)
|
2007-08-01 |
2007-09-12 |
Novartis Ag |
Compositions comprising antigens
|
|
EP2176291A1
(en)
|
2007-08-10 |
2010-04-21 |
Wacker Chemie AG |
Expression of full length igg and secretion into the culture medium of prokaryotic cells
|
|
EP2185190B1
(en)
|
2007-08-31 |
2015-06-24 |
University Of Chicago |
Methods and compositions related to immunizing against staphylococcal lung diseases and conditions
|
|
US20090068288A1
(en)
|
2007-09-07 |
2009-03-12 |
Wayne Kruger |
Topical antiseptic veterinary solution
|
|
US9125863B2
(en)
|
2008-05-22 |
2015-09-08 |
Children's Medical Center Corporation |
Synergistic immunogenic fusion protein-polysaccharide conjugate
|
|
EP2379106A4
(en)
|
2008-12-17 |
2012-06-13 |
Genocea Biosciences Inc |
ANTIGENS OF CHLAMYDIAS AND USES THEREOF
|
|
CN102712680B
(zh)
|
2008-12-24 |
2016-06-22 |
荷兰王国卫生福利和运动部国家公共卫生和环境研究所 |
修饰的肺炎链球菌溶血素(ply)多肽
|
|
EP2208787A1
(en)
|
2009-01-19 |
2010-07-21 |
Université de Liège |
A recombinant alpha-hemolysin polypeptide of Staphylococcus aureus, having a deletion in the stem domain and heterologous sequences inserted
|
|
US8828953B2
(en)
|
2009-04-20 |
2014-09-09 |
NaZura BioHealth, Inc. |
Chemosensory receptor ligand-based therapies
|
|
EP3756684A1
(en)
|
2009-05-22 |
2020-12-30 |
Genocea Biosciences, Inc. |
Vaccines against herpes simplex virus type 2: compositions and methods for eliciting an immune response
|
|
SG10201403702SA
(en)
|
2009-06-29 |
2014-09-26 |
Genocea Biosciences Inc |
Vaccines and compositions against streptococcus pneumoniae
|
|
CN102648003B
(zh)
|
2009-10-09 |
2016-01-13 |
儿童医疗中心有限公司 |
选择性裂解的全细胞疫苗
|
|
EP2335721A1
(en)
|
2009-12-21 |
2011-06-22 |
Institut Pasteur |
Streptavidin and Biotin-based antigen delivery system
|
|
US20110159040A1
(en)
|
2009-12-30 |
2011-06-30 |
Children's Medical Center Corporation |
Novel immunogens and methods for discovery and screening thereof
|
|
CN101797381B
(zh)
|
2010-01-29 |
2012-05-23 |
中国人民解放军第三军医大学 |
乙肝病毒抗原与路易斯寡糖的复合物及其制备方法和应用
|
|
EP2550289A4
(en)
*
|
2010-03-12 |
2013-11-27 |
Childrens Medical Center |
NEW IMMUNOGENES AND METHODS FOR IDENTIFICATION AND SCREENING THEREOF
|
|
US20130115230A1
(en)
|
2010-04-30 |
2013-05-09 |
Augmenta Biologicals, Llc |
Delivery proteins
|
|
CA2849391A1
(en)
|
2010-10-20 |
2012-04-26 |
Genocea Biosciences, Inc. |
Chlamydia antigens and uses thereof
|
|
US9393294B2
(en)
|
2011-01-20 |
2016-07-19 |
Genocea Biosciences, Inc. |
Vaccines and compositions against Streptococcus pneumoniae
|
|
US8580922B2
(en)
|
2011-03-04 |
2013-11-12 |
Shire Human Genetic Therapies, Inc. |
Peptide linkers for polypeptide compositions and methods for using same
|
|
CN103648489A
(zh)
|
2011-05-11 |
2014-03-19 |
儿童医疗中心有限公司 |
多抗原提呈免疫原性组合物及其方法和用途
|
|
WO2014018904A1
(en)
|
2012-07-26 |
2014-01-30 |
Genocea Biosciences, Inc. |
Fused antigen vaccines and compositions against streptococcus pneumoniae
|
|
KR20140075201A
(ko)
|
2012-12-11 |
2014-06-19 |
에스케이케미칼주식회사 |
다가 폐렴구균 다당류-단백질 접합체 조성물
|
|
JP6494527B2
(ja)
|
2013-02-07 |
2019-04-03 |
ザ チルドレンズ メディカル センター コーポレーション |
肺炎球菌のコロニー形成および／または疾患からの保護を提供するタンパク質抗原
|
|
AU2015349787B2
(en)
*
|
2014-11-21 |
2021-07-29 |
The Board Of Regents Of The University Of Oklahoma |
Pneumolysin mutants and methods of use thereof
|
|
CN108367063A
(zh)
|
2015-07-21 |
2018-08-03 |
辉瑞公司 |
包含缀合的荚膜糖抗原的免疫原性组合物及其试剂盒和用途
|
|
WO2018156465A1
(en)
|
2017-02-24 |
2018-08-30 |
Merck Sharp & Dohme Corp. |
Polysaccharide-protein conjugates utilizing diphtheria toxin fragment b as a carrier
|
|
AU2018243910B2
(en)
|
2017-03-28 |
2025-04-10 |
The Children's Medical Center Corporation |
A multiple antigen presenting system (MAPS)-based staphylococcus aureus vaccine, immunogenic composition, and uses thereof
|
|
AU2019215212B2
(en)
|
2018-02-05 |
2025-05-15 |
Sk Bioscience Co., Ltd. |
Multivalent pneumococcal polysaccharide-protein conjugate composition
|
|
CA3091583A1
(en)
|
2018-03-01 |
2019-09-06 |
Biological E Limited |
Expression of pneumococcal surface protein a (pspa)
|
|
IL281204B2
(en)
|
2018-09-12 |
2025-07-01 |
Affinivax Inc |
Multivalent pneumococcal vaccines
|
|
JP7535791B2
(ja)
|
2018-09-12 |
2024-08-19 |
ザ チルドレンズ メディカル センター コーポレーション |
肺炎球菌融合タンパク質ワクチン
|
|
KR20230146620A
(ko)
|
2021-02-17 |
2023-10-19 |
박사이트, 인코포레이티드 |
폴리사카라이드 및 이의 폴리펩타이드 접합체의 정제 방법
|
|
IL326005A
(en)
|
2021-09-09 |
2026-03-01 |
Affinivax Inc |
Multivalent pneumococcal vaccines
|